FDA Approved: VESICARE LS — Original Application (Astellas Pharma US, Inc.)

View source ↗

Summary

FDA approved Vesicare LS (solifenacin succinate) under an original NDA from Astellas Pharma US, Inc. for the treatment of overactive bladder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder
• Urinary Incontinence

Drugs mentioned

• VESICARE LS (SOLIFENACIN SUCCINATE)

Snippet

ORIG AP for VESICARE LS (SOLIFENACIN SUCCINATE)